A CROSS-SECTIONAL STUDY TO DETERMINE THE ENDOSCOPIC FINDINGS IN PATIENTS WITH PPI RESISTANT DYSPEPSIA IN A TERTIARY CARE CENTRE
Main Article Content
Keywords
.
Abstract
Background: Dyspepsia, a common condition marked by upper abdominal discomfort, significantly affects quality of life. While proton pump inhibitors (PPIs) are the standard treatment, a substantial number of patients experience persistent symptoms, a condition known as PPI-resistant dyspepsia. The underlying causes of this resistance are complex and not fully understood, highlighting the need for further investigation, particularly through upper gastrointestinal (GI) endoscopy.
Aim: This cross-sectional study was conducted to determine the endoscopic findings in patients with PPI-resistant dyspepsia at a tertiary care centre. The primary objective was to identify the etiologies causing PPI resistance, while a secondary objective was to determine if associated comorbidities influence this resistance.
Materials and Methods: A total of 71 patients were enrolled in the study. All participants underwent a comprehensive evaluation, including a detailed clinical history, physical examination, and upper GI endoscopy. The study recorded demographic data, presenting symptoms, duration of symptoms, PPI usage, and associated comorbidities. Endoscopic findings were meticulously documented to identify both organic and functional abnormalities.
Results: The mean age of the participants was 41.25 years, with a female predominance (54.9%). The most common presenting symptoms were epigastric burning (97.2%), abdominal pain (94.4%), and bloating (90.1%). Endoscopic evaluation revealed a high prevalence of abnormal findings, with gastritis being the most common observation, followed by esophagitis and peptic ulcers. The study also found that a significant portion of patients had conditions such as H. pylori infection.
Conclusion: The findings of this study demonstrate that a significant number of patients with PPI-resistant dyspepsia have identifiable organic causes, which can be diagnosed through upper GI endoscopy. The results highlight the diagnostic utility of endoscopy in this patient population, as it can reveal underlying pathologies that necessitate a change in management strategy beyond standard acid suppression therapy. These findings support the hypothesis that endoscopic evaluation is a valuable tool for tailoring individualized treatment plans and improving outcomes for patients with PPI-resistant dyspepsia.
References
2. Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, et al. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci 1993;38:1569-80.
3. Camilleri, Michael et al. Prevalence and Socioeconomic Impact of Upper Gastrointestinal Disorders in the United States: Results of the US Upper Gastrointestinal Study .Clinical Gastroenterology and Hepatology, Volume 3, Issue 6, 543 – 552.
4. Ghoshal UC, Singh R. Functional dyspepsia: the Indian scenario. J Assoc Physicians India 2012;60 Suppl:6–8.
5. Sarkar S, et al. Cross sectional study of endoscopic findings among patients with dyspepsia not responding to ppi therapy for 4 weeks in sub himalayan region. Int J Acad Med Pharm 2025; 7 (4); 853-857
6. Yellapu R et al. Upper Gastrointestinal Endoscopic Findings of Patients Presenting with Dyspepsia - A Tertiary Care Centre Experience. International Journal of Contemporary Medical Research 2019;6(9):I36-I39.
7. Onat A, Keleş İ, Sansoy V, Ceyhan K, Uysal Ö, Çetinkaya A, et al. Yetişkinlerimizin 10-yıllık Takibinde Obezite Göstergeleri Artışta: Beden Kitle İndeksi Erkeklerde Koroner Olayların Bağımsız Öngördürücüsü. Türk Kardiyol Derneği Arşivi 2001;29:430-3.
8. Maheswari, et al. Various findings in upper gastrointestinal endoscopy in patients presenting with dyspepsia: A clinical study. International Journal of Surgery Science 2021; 5(1): 290-292
9. Xiao YL, Peng S, Tao J, Wang AJ, Lin JK, Hu PJ, et al. Prevalence and symptom pattern of pathologic esophageal acid reflux in patients with functional dyspepsia based on the Rome III criteria. Am J Gastroenterol 2010;105:2626-31
10. Lu CL, Lang HC, Chang FY, et al. Prevalence and health/social impacts of functional dyspepsia in Taiwan: a study based on the Rome criteria questionnaire survey assisted by endoscopic exclusion among a physical check-up population. Scand J Gastroenterol. 2005;40;402-411.
11. Kumar M, Devarmani SS, et al. A study of clinical and endoscopic findings of dyspepsia patients. International Journal of Life Sciences, Biotechnology and Pharma Research 2025; 14(5):1352-1366
12. Park JM, Choi MG, Cho YK, Lee IS, Kim JI, Kim SW, et al. Functional Gastrointestinal Disorders Diagnosed by Rome III Questionnaire in Korea. J Neurogastroenterol Motil 2011;17:279-86.
13. Bor S, Endoscopic and pathologic findings in patients with dyspepsia in Turkey: Multicenter prospective study (DISPEN). Sözlü bildiri, 28. Ulusal Gastroenteroloji Haftası, 2011. Turk J Gastroenterol 2011;22:(suppl 1):96.
14. Hongo M, Harasawa S, Mine T, Sasaki I, Matsueda K, Kusano M, et al. Large-scale randomized clinical study on functional dyspepsia treatment with mosapride or teprenone: Japan Mosapride Mega-Study ( JMMS). J Gastroenterol Hepatol 2012;27:62-8.

